King pursues patent infringement action against Sandoz over AVINZA®
Clients King Pharmaceuticals, Inc.
Jones Day represents King Pharmaceuticals, Inc. in a Hatch-Waxman patent litigation brought by King against Sandoz. Sandoz filed an Abbreviated New Drug Application seeking to market a generic version of King's AVINZA® product.
King Pharmaceuticals Inc. et al. v. Sandoz Inc., Case No. 2-09-cv-03587 (D.N.J.) (Judge Greenaway, Jr.)